This company listing is no longer active
McKesson Europe Past Earnings Performance
Past criteria checks 0/6
McKesson Europe's earnings have been declining at an average annual rate of -2039.3%, while the Healthcare industry saw earnings growing at 17.7% annually. Revenues have been growing at an average rate of 8.7% per year.
Key information
-2,039.3%
Earnings growth rate
-2,039.3%
EPS growth rate
| Healthcare Industry Growth | 12.6% |
| Revenue growth rate | 8.7% |
| Return on equity | -2.0% |
| Net Margin | -0.6% |
| Last Earnings Update | 31 Mar 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How McKesson Europe makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 22 | 9,257 | -54 | 450 | 0 |
| 31 Mar 21 | 8,518 | 3 | 484 | 0 |
| 31 Mar 20 | 17,118 | -71 | 1,146 | 0 |
| 31 Mar 19 | 16,417 | -47 | 1,159 | 0 |
| 31 Mar 18 | 21,090 | -303 | 1,416 | 0 |
| 31 Mar 17 | 20,644 | -807 | 1,260 | 0 |
| 31 Dec 16 | 20,475 | -76 | 2,333 | 0 |
| 30 Sep 16 | 21,118 | 437 | 1,354 | 0 |
| 30 Jun 16 | 21,265 | 459 | 1,387 | 0 |
| 31 Mar 16 | 21,193 | 487 | 1,428 | 0 |
| 31 Mar 15 | 21,076 | 129 | 1,352 | 0 |
| 31 Dec 14 | 20,647 | 187 | 1,347 | 0 |
| 30 Sep 14 | 21,877 | 79 | 1,454 | 0 |
| 30 Jun 14 | 21,606 | 64 | 1,443 | 0 |
| 31 Mar 14 | 21,426 | 167 | 1,422 | 0 |
| 31 Dec 13 | 21,408 | 165 | 1,419 | 0 |
| 30 Sep 13 | 21,565 | 146 | 1,392 | 0 |
| 30 Jun 13 | 21,753 | 153 | 1,389 | 0 |
| 31 Mar 13 | 21,990 | 99 | 1,418 | 0 |
| 31 Dec 12 | 22,271 | 103 | 1,428 | 0 |
| 30 Sep 12 | 22,339 | 51 | 1,447 | 0 |
| 30 Jun 12 | 22,347 | 72 | 1,440 | 0 |
Quality Earnings: 0OPB is currently unprofitable.
Growing Profit Margin: 0OPB is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if 0OPB's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare 0OPB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 0OPB is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-25.9%).
Return on Equity
High ROE: 0OPB has a negative Return on Equity (-1.96%), as it is currently unprofitable.